8.7
Excellent
376 reviews
- Communication
- 8.8
- Timeliness
- 8.9
- Accuracy
- 7.6
- Staff
- 8.8
- Value
- 8.9
Garry Lesch
5.7
- - Project Management
- - 12 weeks March - May 2024
- - Biotech Company
Reviewed:
Poor communication and missed deadlines caused frustration.
Communication from the project management team was poor, with frequent missed deadlines. This caused significant frustration on our end, as we had to repeatedly chase them for updates. The project eventually got back on track, but the delays were problematic.
Leah Howe
9.2
- - Data Analysis
- - 4 weeks January 2023
- - Pharmaceutical Company
Reviewed:
Thorough data analysis, timely delivery, excellent communication throughout.
The team provided exceptional data analysis services, and the project was completed well within the timeline. Communication was clear and consistent, which made the whole process smooth. Highly recommended for anyone needing reliable clinical data management.
Stacey Parisian
5.8
- - Biostatistical Design
- - 6 weeks February - March 2024
- - Research Institution
Reviewed:
Biostatistical analysis lacked depth, missed key insights.
The biostatistical analysis provided was not as thorough as we had hoped. Some key insights were missed, and we had to engage another provider to get the level of detail we needed. The team seemed overworked and under-resourced.
Maria Hegmann
9
- - Biomarker Development
- - 12 weeks October 2023 - January 2024
- - Research Institution
Reviewed:
Efficient and precise biomarker development.
The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.
Meghan Schinner
6.3
- - Stability Studies
- - 16 months July 2023 - November 2024
- - Pharmaceutical Company
Reviewed:
Stability studies lacked detail, required additional validation.
The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.
Stewart Christiansen
8.9
- - Stability Studies
- - 18 months January 2023 - June 2024
- - Pharmaceutical Company
Reviewed:
Accurate and reliable stability studies, clear reporting.
The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.
Dustin Rodriguez
9.3
- - Project Management
- - 10 weeks July - September 2023
- - Biotech Company
Reviewed:
Seamless project management, results exceeded expectations.
Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.
